Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma [Phase 1]
Phase 1 trial evaluating ADI-PEG 20 plus cisplatin in metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluates hyperthermic intraperitoneal chemotherapy (HIPEC) as first-line therapy for patients with Stage III…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating imatinib mesylate in combination with docetaxel for advanced…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer [Phase 1]
Phase 1 trial assessing perifosine in combination with docetaxel in patients with relapsed epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy [NA]
This clinical trial update compares laparoscopy and laparotomy for malignant ovarian cancer, with the current status listed as unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
This Phase 1 trial update investigates abdominal radiation plus docetaxel for recurrent or persistent advanced ovarian, fallopian tube, or p…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) [NA]
The PERSEE feasibility study evaluating robotic endomicroscopy to better define resection strategies for digestive system cancers and ovaria…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Safety of Antioxidants During GYN Cancer Care [Phase 2]
Phase 2 clinical trial assessing the safety of antioxidant supplements during gynecologic cancer care has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer [Phase 1, Phase 2]
Phase I/II study evaluating Pazopanib in combination with Cyclophosphamide for platinum-resistant recurrent epithelial ovarian cancer has co…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) [Phase 1]
This is a completed Phase 1 clinical trial update for SCH-58500 in patients with fallopian tube cancer, ovarian cancer, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Prevention of Ovarian Cancer in Women Participating in Mammography [NA]
This clinical trial update reports the completion of a study evaluating prevention of ovarian cancer in women participating in mammography.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
This completed Phase 1/Phase 2 study evaluated the feasibility and safety of combining carboplatin-based chemotherapy (carboplatin with Cael…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma [Phase 1]
This Phase 1 trial assesses dose escalation of cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) after surgery in patients w…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating a combination of intravenous and intraperitoneal paclitaxel, intraperitoneal cisplatin, and intravenous be…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas [Phase 2]
Phase 2 trial of sunitinib in metastatic, locally advanced, or locally recurrent sarcomas completed; results posted in 2016 and include desm…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer [EARLY_Phase 1]
An early-phase cancer screening trial for women at high risk of ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer [Phase 1]
Phase 1 safety study of an antisense product in multiple cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer [Phase 2]
MITO-5 is a Phase 2 trial evaluating weekly carboplatin and paclitaxel as first-line chemotherapy for elderly patients with ovarian cancer. …
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer [Phase 2]
A Phase 2 study (MITO-6) tested capecitabine in platinum-resistant ovarian cancer and the trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer [Phase 2]
A Phase 2 trial adding AMG 479 to first-line chemotherapy for optimally debulked epithelial ovarian cancer was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy in patients with ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy [Phase 3]
A Phase 3 trial comparing carboplatin alone versus carboplatin with gemcitabine in patients with advanced epithelial ovarian cancer that has…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel [Phase 2]
Phase 2 trial update evaluating Ombrabulin in platinum-sensitive recurrent ovarian cancer patients treated with carboplatin and paclitaxel. …
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer [Phase 1]
A Phase I safety study of a cancer vaccine for HLA-A2 positive advanced ovarian, breast, and prostate cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases [Phase 1]
Phase 1 clinical trial update on EMD 525797 for colorectal and ovarian cancer patients with liver metastases; study status is completed with…